www.citrix.com




WARNING! This computer system is the property of Lifetime Healthcare Inc. and may be accessed only by authorized users.
Unauthorized use of this system is strictly prohibited and may be subject to criminal prosecution or civil proceedings.
All activity is monitored and there should be no expectation of individual privacy.

CONFIDENTIAL COMMUNICATION
PROHIBITION ON REDISCLOSURE

Your organization is receiving the accompanying information for the purposes set forth in, and in accordance with the terms of, the underlying agreement(s) between the parties, including the business associate agreement, as applicable. The information provided is confidential and proprietary to Excellus Health Plan, Inc., [d/b/a Excellus BlueCross BlueShield/ Univera Healthcare], and is subject to the confidentiality provisions in the underlying agreement(s). To the extent the information provided constitutes confidential HIV-related information protected under New York State Public Health Law Article 27-F, and/or Patient Identifying Information as defined under 42 CFR Part 2, the following statements apply.For Confidential HIV-related Information:The information has been disclosed to you from confidential records which are protected by state law. State law prohibits you from making any further disclosure of this information without the specific written consent of the person to whom it pertains, or as otherwise permitted by law. Any unauthorized further disclosure in violation of state law may result in a fine or jail sentence or both. A general authorization for the release of medical or other information is NOT sufficient authorization for further disclosure.For Patient Identifying Information:The information has been disclosed to you from records protected by federal confidentiality rules (42 CFR part 2). The federal rules prohibit you from making any further disclosure of information in this record that identifies a patient as having or having had a substance use disorder either directly, by reference to publicly available information, or through verification of such identification by another person unless further disclosure is expressly permitted by the written consent of the individual whose information is being disclosed or as otherwise permitted by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose (see § 2.31). The federal rules restrict any use of the information to investigate or prosecute with regard to a crime any patient with a substance use disorder, except as provided at §§ 2.12(c)(5) and 2.65.



WARNING! This computer system is the property of Lifetime Healthcare Inc. and may be accessed only by authorized users.
Unauthorized use of this system is strictly prohibited and may be subject to criminal prosecution or civil proceedings.
All activity is monitored and there should be no expectation of individual privacy.

CONFIDENTIAL COMMUNICATION
PROHIBITION ON REDISCLOSURE

Your organization is receiving the accompanying information for the purposes set forth in, and in accordance with the terms of, the underlying agreement(s) between the parties, including the business associate agreement, as applicable. The information provided is confidential and proprietary to Excellus Health Plan, Inc., [d/b/a Excellus BlueCross BlueShield/ Univera Healthcare], and is subject to the confidentiality provisions in the underlying agreement(s). To the extent the information provided constitutes confidential HIV-related information protected under New York State Public Health Law Article 27-F, and/or Patient Identifying Information as defined under 42 CFR Part 2, the following statements apply.For Confidential HIV-related Information:The information has been disclosed to you from confidential records which are protected by state law. State law prohibits you from making any further disclosure of this information without the specific written consent of the person to whom it pertains, or as otherwise permitted by law. Any unauthorized further disclosure in violation of state law may result in a fine or jail sentence or both. A general authorization for the release of medical or other information is NOT sufficient authorization for further disclosure.For Patient Identifying Information:The information has been disclosed to you from records protected by federal confidentiality rules (42 CFR part 2). The federal rules prohibit you from making any further disclosure of information in this record that identifies a patient as having or having had a substance use disorder either directly, by reference to publicly available information, or through verification of such identification by another person unless further disclosure is expressly permitted by the written consent of the individual whose information is being disclosed or as otherwise permitted by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose (see § 2.31). The federal rules restrict any use of the information to investigate or prosecute with regard to a crime any patient with a substance use disorder, except as provided at §§ 2.12(c)(5) and 2.65.


WARNING! This computer system is the property of Lifetime Healthcare Inc. and may be accessed only by authorized users.
Unauthorized use of this system is strictly prohibited and may be subject to criminal prosecution or civil proceedings.
All activity is monitored and there should be no expectation of individual privacy.

CONFIDENTIAL COMMUNICATION
PROHIBITION ON REDISCLOSURE

Your organization is receiving the accompanying information for the purposes set forth in, and in accordance with the terms of, the underlying agreement(s) between the parties, including the business associate agreement, as applicable. The information provided is confidential and proprietary to Excellus Health Plan, Inc., [d/b/a Excellus BlueCross BlueShield/ Univera Healthcare], and is subject to the confidentiality provisions in the underlying agreement(s). To the extent the information provided constitutes confidential HIV-related information protected under New York State Public Health Law Article 27-F, and/or Patient Identifying Information as defined under 42 CFR Part 2, the following statements apply.For Confidential HIV-related Information:The information has been disclosed to you from confidential records which are protected by state law. State law prohibits you from making any further disclosure of this information without the specific written consent of the person to whom it pertains, or as otherwise permitted by law. Any unauthorized further disclosure in violation of state law may result in a fine or jail sentence or both. A general authorization for the release of medical or other information is NOT sufficient authorization for further disclosure.For Patient Identifying Information:The information has been disclosed to you from records protected by federal confidentiality rules (42 CFR part 2). The federal rules prohibit you from making any further disclosure of information in this record that identifies a patient as having or having had a substance use disorder either directly, by reference to publicly available information, or through verification of such identification by another person unless further disclosure is expressly permitted by the written consent of the individual whose information is being disclosed or as otherwise permitted by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose (see § 2.31). The federal rules restrict any use of the information to investigate or prosecute with regard to a crime any patient with a substance use disorder, except as provided at §§ 2.12(c)(5) and 2.65.

|

|

| | |

|

| | |

|